down arrow

Runben Biotechnology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: CNE100006DK5
CNY
20.39
-15.6 (-43.35%)

Sep 23

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

17.7730.00
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore

Dashboard

1

Positive results in Jun 26

  • OPERATING CASH FLOW(Y) Highest at CNY 348.92 MM
  • INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
  • DIVIDEND PAYOUT RATIO(Y) Highest at 65.7%
2

With ROE of 14.25%, it has a very attractive valuation with a 2.90 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

CNY 2,172 Million (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.29%

stock-summary
Debt Equity

-0.50

stock-summary
Return on Equity

14.25%

stock-summary
Price to Book

0.96

Revenue and Profits:
Net Sales:
787 Million
(Quarterly Results - Jun 2026)
Net Profit:
172 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-34.54%
0%
-34.54%
6 Months
-11.85%
0%
-11.85%
1 Year
6.14%
0%
6.14%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Runben Biotechnology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
40.35%
EBIT Growth (5y)
148.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.63
Tax Ratio
12.50%
Dividend Payout Ratio
59.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.84%
ROE (avg)
13.24%

Valuation key factors

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.90
EV to EBIT
16.47
EV to EBITDA
15.69
EV to Capital Employed
4.82
EV to Sales
3.48
PEG Ratio
2.77
Dividend Yield
0.42%
ROCE (Latest)
29.30%
ROE (Latest)
14.25%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 20.10% vs 13.48% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 20.38% vs -0.90% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "786.80",
          "val2": "655.10",
          "chgp": "20.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "200.90",
          "val2": "166.20",
          "chgp": "20.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.80",
          "val2": "-4.00",
          "chgp": "195.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "172.50",
          "val2": "143.30",
          "chgp": "20.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "247.80%",
          "val2": "245.00%",
          "chgp": "0.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.25% vs 27.39% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.76% vs 32.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,534.00",
          "val2": "1,308.30",
          "chgp": "17.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "350.20",
          "val2": "329.40",
          "chgp": "6.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "3.60",
          "chgp": "-77.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "314.50",
          "val2": "300.20",
          "chgp": "4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "213.80%",
          "val2": "235.50%",
          "chgp": "-2.17%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
786.80
655.10
20.10%
Operating Profit (PBDIT) excl Other Income
200.90
166.20
20.88%
Interest
0.00
0.00
Exceptional Items
3.80
-4.00
195.00%
Consolidate Net Profit
172.50
143.30
20.38%
Operating Profit Margin (Excl OI)
247.80%
245.00%
0.28%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2026 is 20.10% vs 13.48% in Jun 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 20.38% vs -0.90% in Jun 2025

All Quarterly Resultsstock-summary

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,534.00
1,308.30
17.25%
Operating Profit (PBDIT) excl Other Income
350.20
329.40
6.31%
Interest
0.20
0.20
Exceptional Items
0.80
3.60
-77.78%
Consolidate Net Profit
314.50
300.20
4.76%
Operating Profit Margin (Excl OI)
213.80%
235.50%
-2.17%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 17.25% vs 27.39% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 4.76% vs 32.83% in Dec 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About Runben Biotechnology Co., Ltd. stock-summary
stock-summary
Runben Biotechnology Co., Ltd.
FMCG
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading